Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 216665
Company: SOLENO THERAP
Company: SOLENO THERAP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| VYKAT XR | DIAZOXIDE CHOLINE | 25MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | None | Yes | No |
| VYKAT XR | DIAZOXIDE CHOLINE | 75MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | None | Yes | No |
| VYKAT XR | DIAZOXIDE CHOLINE | 150MG | TABLET, EXTENDED RELEASE;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 03/26/2025 | ORIG-1 | Approval | Type 2 - New Active Ingredient | PRIORITY; Orphan |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/216665s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/216665Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2026/216665Orig1s000TOC.html |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 03/26/2025 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/216665s000lbl.pdf |